Developer docs
API playgroundTry for free, no card

Search company profiles

Molecular Testing Labs

Full company profile

uuid0006k7l

Namestring
Molecular Testing Labs
Legal namestring
Blackfly Investments, LLC, dba Molecular Testing Labs
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Molecular Testing Labs (operating as CareNexa, LLC dba Molecular Testing Labs) is a privately held clinical diagnostic laboratory founded in 2011 and headquartered in Vancouver, WA, with a secondary laboratory in Irving, TX. The company is CLIA-certified (high-complexity testing) and CAP-accredited at both locations, and operates an FDA-cleared self-collection diagnostic (the simpli-COLLECT STI Test). MTL's core capability is enabling at-home and alternative-site specimen collection through dried blood spot cards, oral swabs, urine samples, and multi-site STI kits, combined with vertical integration into kit construction and nationwide distribution via USPS and FedEx. The laboratory processes hundreds of thousands of tests per month across an assay menu spanning STI/sexual health, hormone panels, toxicology/drug screening, pharmacogenetics, methylation and fitness/nutrition genetics, UTI PCR, GLP-1 weight management monitoring, and colorectal cancer screening (FIT).

MTL serves five primary customer segments: healthcare providers (clinics, physicians, telehealth), health plans (population health and HEDIS/Star/MIPS gap closure), digital health and retail health platforms (white-label and API-embedded integrations), public health organizations (epidemiological screening programs), and clinical studies/trials. It goes to market through three motions: direct enterprise sales to providers and health plans, channel partnerships with digital health companies, and an API-first integration model supported by a comprehensive REST API with webhook notifications and a web-based Laboratory Information System portal (the Molecular Portal). Patient-facing kit registration and results delivery operate through a separate self-serve portal, and the company markets a consumer-facing wellness sub-brand called CareNexa Wellness.

MTL generates revenue through laboratory diagnostic testing services billed to Medicare, Medicaid, commercial insurance, workers' compensation, and self-pay patients; recurring subscription-style access fees for the LIS portal; and managed-services contracts for population health and gaps-in-care programs. The legal entity structure includes CareNexa, LLC and Blackfly Investments, LLC, both operating under the Molecular Testing Labs trade name in Washington state. No venture capital, private equity, or institutional investor ownership has been disclosed in the available materials, and the company is not publicly traded.

Short descriptiontext

Molecular Testing Labs is a CLIA-certified, CAP-accredited clinical diagnostic laboratory operating in Vancouver, WA and Irving, TX that enables at-home self-collection specimen testing across STI, hormone, pharmacogenetics, toxicology, and wellness panels, serving healthcare providers, health plans, digital health platforms, public health agencies, and clinical trial sponsors via a web portal and REST API.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersVancouver, United States
HQ citystring
Vancouver
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical diagnostic laboratory, at-home specimen collection, molecular diagnostic testing, STI screening services, pharmacogenomic testing
Industry3 codes
PRIMARYHLAFAMAB
Clinical Chemistry & Immunoassay Laboratories
SECONDARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
SECONDARYHLAFAMAL
Clinical Research & Trial Central Laboratories
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Diagnostic Laboratory Services
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Laboratory Diagnostic Testing Services
TypeSubscription Recurring
Description

Core revenue from processing clinical diagnostic tests for healthcare providers, health plans, and patients. Tests are billed to Medicare, Medicaid, commercial insurance, workers' compensation, or self-pay patients. The company offers comprehensive assay menu including STI testing, hormone panels, toxicology, pharmacogenetics, and wellness testing.

moleculartestinglabs.com
2Healthcare Operations and Portal Services
TypeSubscription Recurring
Description

Provides web-based Laboratory Information System (LIS) portal access to healthcare professionals for test ordering and results retrieval, with associated service fees.

3Population Health and Gaps in Care Programs
TypeManaged Services
Description

Contracts with health plans to close care gaps through diagnostic testing, including HEDIS, Star, and MIPS measure support. May include claims-based reimbursement for testing services.

moleculartestinglabs.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1Insurance-based laboratory testing
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Laboratory services billed to Medicare, Medicaid, commercial insurance, or workers' compensation based on contracted rates and fee schedules.

GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1CareNexa Wellness
Description

Wellness testing brand offering fitness and nutrition genetic testing panels including 34 gene targets for fitness and nutrition and 16 gene targets for methylation.

moleculartestinglabs.com
Core offering1 text field

Molecular Testing Labs operates a CLIA-certified, CAP-accredited clinical diagnostic laboratory providing at-home specimen collection kits and molecular diagnostic testing for healthcare providers, health plans, digital health companies, public health organizations, and clinical study sponsors. The company offers a comprehensive test menu including STI screening, hormone panels, toxicology, pharmacogenetics, GLP-1 monitoring, wellness testing, and dried blood spot testing, supported by in-house kit construction, laboratory processing, and results delivery through a web-based LIS portal and a REST API.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Processes hundreds of thousands of diagnostic tests on clinically and non-clinically collected samples every month
+1 more record
Product overview1 text field

Molecular Testing Labs operates as a diagnostic laboratory offering a unified platform of specimen collection, testing, and results delivery services. The core offering consists of the Molecular Portal (LIS) and Molecular API, which together enable healthcare providers and partners to order tests, manage kits, and retrieve results. The product portfolio includes FDA-cleared simpli-COLLECT STI self-collection kits, dried blood spot testing, and specialized panels for GLP-1 weight management, drug screening, UTI, hormones, pharmacogenetics, and wellness (via CareNexa Wellness brand). Testing is processed through CLIA-certified and CAP-accredited laboratories with in-house logistics and fulfillment capabilities.

Product and service15 records
1Molecular Portal (LIS Portal)
CategoryLaboratory Information System
Description

Web-based Laboratory Information System portal enabling healthcare providers to place test orders, track kit status, and retrieve patient results through a secure online interface.

2Molecular API
CategoryAPI Platform
Description

RESTful API enabling programmatic access to lab ordering, kit management, patient data retrieval, and webhook-based result notifications for integration with partner systems.

3simpli-COLLECT STI Test
CategoryDiagnostic Test Kit
Description

FDA-cleared self-collection test kit for STI screening enabling patients to collect specimens at home from oral, genital, and rectal sites for chlamydia, gonorrhea, and other sexually transmitted infections.

4Dried Blood Spot Testing
CategoryDiagnostic Testing
Description

Self-collection diagnostic testing using finger-prick blood samples collected on specialized dried blood spot cards, enabling at-home specimen collection with ambient-temperature shipping.

5GLP-1 Weight Management Testing
CategoryDiagnostic Testing
Description

Diagnostic panel monitoring glycemic control, lipid levels, thyroid function, and renal efficiency for patients on GLP-1 weight loss medications, with recommended testing every three months.

6Drug Testing and Screening
CategoryDiagnostic Testing
Description

Comprehensive toxicology services including oral fluid drug confirmations for substances such as amphetamines, benzodiazepines, opioids, and other drugs, supporting substance abuse detection and treatment monitoring.

7UTI PCR Testing
CategoryDiagnostic Testing
Description

Polymerase chain reaction testing for urinary tract infection pathogens including bacterial and fungal targets, with antibiotic resistance gene detection capabilities.

8Hormone Testing
CategoryDiagnostic Testing
Description

Comprehensive hormone panel including AMH, estradiol, progesterone, DHEA-S, testosterone, LH, FSH, TSH, free T4, and TPO antibodies for assessment of reproductive and thyroid health.

9Methylation and Fitness + Nutrition Testing
CategoryGenetic Testing
Description

Genetic testing panels analyzing 34 fitness and nutrition gene targets and 16 methylation pathway genes to provide personalized recommendations for diet, exercise, and health optimization.

10CareNexa Wellness
CategoryWellness Testing
Description

Consumer-facing wellness sub-brand offering direct-to-patient health and wellness testing including thyroid panels, fitness nutrition genetic testing, and methylation analysis.

11Pharmacogenetics Testing
CategoryGenetic Testing
Description

Genetic testing panels covering addiction risk, cardiovascular disease, prenatal screening, ADHD, mental health risk, pain management, and PTSD risk through analysis of relevant gene variants.

12STI & Sexual Health Testing
CategoryDiagnostic Testing
Description

Comprehensive sexually transmitted infection screening including HIV, hepatitis B and C, chlamydia, gonorrhea, Mycoplasma genitalium, HPV, syphilis, RPR, and trichomonas testing with multi-site collection options.

13Cancer Screening (FIT)
CategoryDiagnostic Testing
Description

Fecal immunochemical test (FIT) for colorectal cancer screening providing non-invasive early detection.

14Kit Registration Portal
CategoryPatient Portal
Description

Patient-facing web portal for registering test kits, creating accounts, retrieving diagnostic results, and managing personal health information and billing.

15Gaps in Care Solutions
CategoryPopulation Health Program
Description

Population health testing program helping health plans close care gaps for HEDIS, Star, and MIPS metrics through member engagement, self-collection kits, and provider reporting.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Largest US clinical reference laboratory offering a full menu of diagnostic testing across all 50 states. Directly comparable in CLIA-certified clinical chemistry, immunoassay, molecular, and esoteric testing, with much broader geographic reach and entrenched payor contracts.

TypeBroad incumbent
Description

Major national clinical laboratory network with overlapping services in clinical chemistry, molecular diagnostics, pharmacogenetics, and women's health testing. Competes for the same healthcare provider, health plan, and clinical study customers as Molecular Testing Labs.

TypeDirect peer
Description

Direct-to-consumer at-home diagnostics company offering self-collection test kits across hormone, STI, and wellness categories. Closely aligned business model and product set with MTL's CareNexa Wellness and self-collection capabilities.

TypeDirect peer
Description

DTC at-home testing company offering panels for hormones, STIs, thyroid, and wellness through self-collected samples. Direct competitor in the consumer-facing self-collection segment where Molecular Testing Labs operates via CareNexa Wellness.

TypeDirect peer
Description

API-first lab platform enabling telehealth and digital health companies to integrate at-home diagnostic testing. Highly comparable to MTL's API-driven white-label partner model serving digital health and retail health customers.

TypeDirect peer
Description

Specialty clinical laboratory offering esoteric diagnostics, women's health, oncology, and infectious disease testing. Comparable mid-to-large independent lab serving providers and health plans with similar test menu breadth.

TypeDirect peer
Description

At-home STI and wellness testing company shipping self-collection kits directly to consumers. Closely comparable product offering to MTL's STI testing and wellness categories with similar DTC fulfillment model.

TypeBroad incumbent
Description

International clinical laboratory operator with US operations providing full-service diagnostic testing to providers and health systems. Comparable in clinical lab service model and regulatory profile, with broader scale.

TypeBroad incumbent
Description

Global clinical diagnostics provider including specialty esoteric testing, pharmacogenetics, and clinical trial support. Overlaps with MTL's clinical trial and pharmacogenomic testing services at larger scale.

10XIFIN
TypeOthers
Description

Health information technology vendor providing billing, LIS, and revenue cycle management to diagnostic laboratories. MTL's patient portal is hosted on XIFIN infrastructure, making XIFIN a strategic infrastructure partner rather than a direct competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
Yes

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance11 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Molecular Testing Labs

Clinical Diagnostic Laboratory Servicesmoleculartestinglabs.com

Molecular Testing Labs is a CLIA-certified, CAP-accredited clinical diagnostic laboratory operating in Vancouver, WA and Irving, TX that enables at-home self-collection specimen testing across STI, hormone, pharmacogenetics, toxicology, and wellness panels, serving healthcare providers, health plans, digital health platforms, public health agencies, and clinical trial sponsors via a web portal and REST API.

What Molecular Testing Labs does

Molecular Testing Labs (operating as CareNexa, LLC dba Molecular Testing Labs) is a privately held clinical diagnostic laboratory founded in 2011 and headquartered in Vancouver, WA, with a secondary laboratory in Irving, TX. The company is CLIA-certified (high-complexity testing) and CAP-accredited at both locations, and operates an FDA-cleared self-collection diagnostic (the simpli-COLLECT STI Test). MTL's core capability is enabling at-home and alternative-site specimen collection through dried blood spot cards, oral swabs, urine samples, and multi-site STI kits, combined with vertical integration into kit construction and nationwide distribution via USPS and FedEx. The laboratory processes hundreds of thousands of tests per month across an assay menu spanning STI/sexual health, hormone panels, toxicology/drug screening, pharmacogenetics, methylation and fitness/nutrition genetics, UTI PCR, GLP-1 weight management monitoring, and colorectal cancer screening (FIT).

MTL serves five primary customer segments: healthcare providers (clinics, physicians, telehealth), health plans (population health and HEDIS/Star/MIPS gap closure), digital health and retail health platforms (white-label and API-embedded integrations), public health organizations (epidemiological screening programs), and clinical studies/trials. It goes to market through three motions: direct enterprise sales to providers and health plans, channel partnerships with digital health companies, and an API-first integration model supported by a comprehensive REST API with webhook notifications and a web-based Laboratory Information System portal (the Molecular Portal). Patient-facing kit registration and results delivery operate through a separate self-serve portal, and the company markets a consumer-facing wellness sub-brand called CareNexa Wellness.

MTL generates revenue through laboratory diagnostic testing services billed to Medicare, Medicaid, commercial insurance, workers' compensation, and self-pay patients; recurring subscription-style access fees for the LIS portal; and managed-services contracts for population health and gaps-in-care programs. The legal entity structure includes CareNexa, LLC and Blackfly Investments, LLC, both operating under the Molecular Testing Labs trade name in Washington state. No venture capital, private equity, or institutional investor ownership has been disclosed in the available materials, and the company is not publicly traded.

Molecular Testing Labs firmographics

Firmographics
Name
Molecular Testing Labs
Legal name
Blackfly Investments, LLC, dba Molecular Testing Labs
Website
https://moleculartestinglabs.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
101–250 employees
Short description
Molecular Testing Labs is a CLIA-certified, CAP-accredited clinical diagnostic laboratory operating in Vancouver, WA and Irving, TX that enables at-home self-collection specimen testing across STI, hormone, pharmacogenetics, toxicology, and wellness panels, serving healthcare providers, health plans, digital health platforms, public health agencies, and clinical trial sponsors via a web portal and REST API.
Ownership category
akta.pro rank

Molecular Testing Labs industry classification

Industry
Product category
Clinical Diagnostic Laboratory Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAFAMAB
Clinical Chemistry & Immunoassay Laboratories
SECONDARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
SECONDARYHLAFAMAL
Clinical Research & Trial Central Laboratories

Keywords

  • Clinical diagnostic laboratory
  • At-home specimen collection
  • Molecular diagnostic testing
  • STI screening services
  • Pharmacogenomic testing

Where Molecular Testing Labs is headquartered

Location

Headquarters

HQ city
Vancouver
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Molecular Testing Labs business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Laboratory Diagnostic Testing Services: Core revenue from processing clinical diagnostic tests for healthcare providers, health plans, and patients. Tests are billed to Medicare, Medicaid, commercial insurance, workers' compensation, or self-pay patients. The company offers comprehensive assay menu including STI testing, hormone panels, toxicology, pharmacogenetics, and wellness testing.
  2. Healthcare Operations and Portal Services: Provides web-based Laboratory Information System (LIS) portal access to healthcare professionals for test ordering and results retrieval, with associated service fees.
  3. Population Health and Gaps in Care Programs: Contracts with health plans to close care gaps through diagnostic testing, including HEDIS, Star, and MIPS measure support. May include claims-based reimbursement for testing services.

Pricing tiers

ModelBillingPrice
SubscriptionPay-as-you-goInsurance-based laboratory testing

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

Molecular Testing Labs product offering

Product offering

Core offering

Molecular Testing Labs operates a CLIA-certified, CAP-accredited clinical diagnostic laboratory providing at-home specimen collection kits and molecular diagnostic testing for healthcare providers, health plans, digital health companies, public health organizations, and clinical study sponsors. The company offers a comprehensive test menu including STI screening, hormone panels, toxicology, pharmacogenetics, GLP-1 monitoring, wellness testing, and dried blood spot testing, supported by in-house kit construction, laboratory processing, and results delivery through a web-based LIS portal and a REST API.

Product overview

Molecular Testing Labs operates as a diagnostic laboratory offering a unified platform of specimen collection, testing, and results delivery services. The core offering consists of the Molecular Portal (LIS) and Molecular API, which together enable healthcare providers and partners to order tests, manage kits, and retrieve results. The product portfolio includes FDA-cleared simpli-COLLECT STI self-collection kits, dried blood spot testing, and specialized panels for GLP-1 weight management, drug screening, UTI, hormones, pharmacogenetics, and wellness (via CareNexa Wellness brand). Testing is processed through CLIA-certified and CAP-accredited laboratories with in-house logistics and fulfillment capabilities.

Differentiator

Problem solved

Functional benefit

Brands

  • CareNexa Wellness: Wellness testing brand offering fitness and nutrition genetic testing panels including 34 gene targets for fitness and nutrition and 16 gene targets for methylation.

Products and services

  • Molecular Portal (LIS Portal) Web-based Laboratory Information System portal enabling healthcare providers to place test orders, track kit status, and retrieve patient results through a secure online interface.
  • Molecular API RESTful API enabling programmatic access to lab ordering, kit management, patient data retrieval, and webhook-based result notifications for integration with partner systems.
  • simpli-COLLECT STI Test FDA-cleared self-collection test kit for STI screening enabling patients to collect specimens at home from oral, genital, and rectal sites for chlamydia, gonorrhea, and other sexually transmitted infections.
  • Dried Blood Spot Testing Self-collection diagnostic testing using finger-prick blood samples collected on specialized dried blood spot cards, enabling at-home specimen collection with ambient-temperature shipping.
  • GLP-1 Weight Management Testing Diagnostic panel monitoring glycemic control, lipid levels, thyroid function, and renal efficiency for patients on GLP-1 weight loss medications, with recommended testing every three months.
  • Drug Testing and Screening Comprehensive toxicology services including oral fluid drug confirmations for substances such as amphetamines, benzodiazepines, opioids, and other drugs, supporting substance abuse detection and treatment monitoring.
  • UTI PCR Testing Polymerase chain reaction testing for urinary tract infection pathogens including bacterial and fungal targets, with antibiotic resistance gene detection capabilities.
  • Hormone Testing Comprehensive hormone panel including AMH, estradiol, progesterone, DHEA-S, testosterone, LH, FSH, TSH, free T4, and TPO antibodies for assessment of reproductive and thyroid health.
  • Methylation and Fitness + Nutrition Testing Genetic testing panels analyzing 34 fitness and nutrition gene targets and 16 methylation pathway genes to provide personalized recommendations for diet, exercise, and health optimization.
  • CareNexa Wellness Consumer-facing wellness sub-brand offering direct-to-patient health and wellness testing including thyroid panels, fitness nutrition genetic testing, and methylation analysis.
  • Pharmacogenetics Testing Genetic testing panels covering addiction risk, cardiovascular disease, prenatal screening, ADHD, mental health risk, pain management, and PTSD risk through analysis of relevant gene variants.
  • STI & Sexual Health Testing Comprehensive sexually transmitted infection screening including HIV, hepatitis B and C, chlamydia, gonorrhea, Mycoplasma genitalium, HPV, syphilis, RPR, and trichomonas testing with multi-site collection options.
  • Cancer Screening (FIT) Fecal immunochemical test (FIT) for colorectal cancer screening providing non-invasive early detection.
  • Kit Registration Portal Patient-facing web portal for registering test kits, creating accounts, retrieving diagnostic results, and managing personal health information and billing.
  • Gaps in Care Solutions Population health testing program helping health plans close care gaps for HEDIS, Star, and MIPS metrics through member engagement, self-collection kits, and provider reporting.

Quantifiable outcome

  • Processes hundreds of thousands of diagnostic tests on clinically and non-clinically collected samples every month
  • +1 more outcomes

Companies that use Molecular Testing Labs

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles6 records

Molecular Testing Labs technology and API

Technology

Technology focussed No

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Molecular Testing Labs partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Molecular Testing Labs competitors and assessment

Company assessment

Broad incumbents

  • Quest Diagnostics: Largest US clinical reference laboratory offering a full menu of diagnostic testing across all 50 states. Directly comparable in CLIA-certified clinical chemistry, immunoassay, molecular, and esoteric testing, with much broader geographic reach and entrenched payor contracts.
  • Labcorp: Major national clinical laboratory network with overlapping services in clinical chemistry, molecular diagnostics, pharmacogenetics, and women's health testing. Competes for the same healthcare provider, health plan, and clinical study customers as Molecular Testing Labs.
  • Sonic Healthcare USA: International clinical laboratory operator with US operations providing full-service diagnostic testing to providers and health systems. Comparable in clinical lab service model and regulatory profile, with broader scale.
  • Eurofins Clinical Diagnostics: Global clinical diagnostics provider including specialty esoteric testing, pharmacogenetics, and clinical trial support. Overlaps with MTL's clinical trial and pharmacogenomic testing services at larger scale.

Direct peers

  • LetsGetChecked: Direct-to-consumer at-home diagnostics company offering self-collection test kits across hormone, STI, and wellness categories. Closely aligned business model and product set with MTL's CareNexa Wellness and self-collection capabilities.
  • Everlywell: DTC at-home testing company offering panels for hormones, STIs, thyroid, and wellness through self-collected samples. Direct competitor in the consumer-facing self-collection segment where Molecular Testing Labs operates via CareNexa Wellness.
  • ixlayer: API-first lab platform enabling telehealth and digital health companies to integrate at-home diagnostic testing. Highly comparable to MTL's API-driven white-label partner model serving digital health and retail health customers.
  • BioReference Laboratories: Specialty clinical laboratory offering esoteric diagnostics, women's health, oncology, and infectious disease testing. Comparable mid-to-large independent lab serving providers and health plans with similar test menu breadth.
  • myLAB Box: At-home STI and wellness testing company shipping self-collection kits directly to consumers. Closely comparable product offering to MTL's STI testing and wellness categories with similar DTC fulfillment model.

Others

  • XIFIN: Health information technology vendor providing billing, LIS, and revenue cycle management to diagnostic laboratories. MTL's patient portal is hosted on XIFIN infrastructure, making XIFIN a strategic infrastructure partner rather than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Molecular Testing Labs social profiles

Digital presence

Molecular Testing Labs compliance and trust

Trust signal

Compliance11 records

Molecular Testing Labs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Molecular Testing Labs leadership team

Management profile

Number of profiles

Profiles6 records

Molecular Testing Labs funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Molecular Testing Labs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Molecular Testing Labs

What does Molecular Testing Labs do?

Molecular Testing Labs operates a CLIA-certified, CAP-accredited clinical diagnostic laboratory providing at-home specimen collection kits and molecular diagnostic testing for healthcare providers, health plans, digital health companies, public health organizations, and clinical study sponsors. The company offers a comprehensive test menu including STI screening, hormone panels, toxicology, pharmacogenetics, GLP-1 monitoring, wellness testing, and dried blood spot testing, supported by in-house kit construction, laboratory processing, and results delivery through a web-based LIS portal and a REST API.

Is Molecular Testing Labs a public or private company?

Molecular Testing Labs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Molecular Testing Labs founded?

Molecular Testing Labs was founded in 2011. It employs 101 to 250 people.

Where is Molecular Testing Labs based?

Molecular Testing Labs is headquartered in Vancouver, United States, in the North America region.

How does Molecular Testing Labs make money?

Three revenue lines are on record. Laboratory Diagnostic Testing Services are the primary driver. The others are healthcare Operations and Portal Services and population Health and Gaps in Care Programs.

Who are Molecular Testing Labs's main competitors?

Broad incumbents on record are Quest Diagnostics, Labcorp, Sonic Healthcare USA and Eurofins Clinical Diagnostics. Direct peers are LetsGetChecked, Everlywell, ixlayer, BioReference Laboratories and myLAB Box. XIFIN is listed as an others.

Does Molecular Testing Labs have an API?

Yes. REST API supporting lab order management (create, retrieve, update, delete orders), kit management (tracking, registration, bulk tracking), patient information retrieval and updates, and webhook notifications for order status changes. Authentication uses user token and practice/distributor ID. Supports multiple lines of business (SC, DNA, FIT, CGX, ID) with specific panel codes for different test types. Developer documentation is at go.moleculartestinglabs.com/support-api.

What industry is Molecular Testing Labs in?

Molecular Testing Labs's product category is Clinical Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAFAMAB, Clinical Chemistry & Immunoassay Laboratories, with a secondary code of HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MoleculartestinglabsClinical & Diagnostic Lab PartnerMolecular Testing Labs is a diagnostic partner that processes hundreds of thousands of tests monthly, offering services such as GLP-1 weight management testing and drug screening. The company maintains CLIA certification and CAP accreditation to ensure quality and compliance for partners including clinics, digital health companies, and public health departments. Its mission focuses on making diagnostic care accessible through advanced science and innovative testing solutions.Clinical Lab ProductsWomen's Health Platform to Offer Home STI TestTia Health, a women's healthcare platform, partnered with Molecular Testing Labs to offer an FDA-cleared home-collection STI test using Abbott's simpli-COLLECT platform, detecting chlamydia, gonorrhea, trichomonas and mycoplasma genitalium. Patients order through a clinician, collect samples at home, ship them for testing via the Alinity m STI Assay, and receive results from a Tia provider.MoleculartestinglabsTia Health and Molecular Testing Labs Partner to Launch the First-Ever FDA-Cleared Home-Collected 4-Plex STI TestTia Health and Molecular Testing Labs have partnered to launch the first FDA-cleared home-collection kit for detecting four common sexually transmitted infections in the United States. The test utilizes Abbott’s simpli-COLLECT technology, allowing patients to collect specimens at home and receive results via Tia's telehealth platform. This collaboration aims to reduce stigma and improve access to private, comprehensive STI diagnostics.PR NewswireTia Health and Molecular Testing Labs Partner to Launch the First-Ever FDA-Cleared Home-Collected 4-Plex STI TestTia Health and Molecular Testing Labs have partnered to launch the first FDA-cleared home-collection kit that simultaneously detects four common sexually transmitted infections — Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium — using Abbott's simpli-COLLECT STI Test technology. Patients can order the kit through a Tia clinician via telemedicine or in-person visits, collect their specimen at home, ship it to MTL's laboratory, and receive results and any necessary treatment from a Tia provider. The companies say the at-home option reduces stigma barriers and represents the start of Tia's broader home-testing strategy as part of its hybrid care model for women.MatrixmedicalnetworkMedical Diagnostic Coding Press ReleaseMatrix Medical Network announced a strategic partnership with Molecular Testing Labs (MTL) to enhance its home-based diagnostic screening services. The collaboration integrates MTL's advanced molecular diagnostics and novel sample collection kits with Matrix's network of nurse practitioners to improve accuracy, access, and patient outcomes. This initiative aims to close care gaps and improve chronic illness detection for patients across the United States.MoleculartestinglabsMatrix Medical Network Announces Strategic Partnership with Molecular Testing Labs to Enhance In-Home Diagnostic OfferingsMatrix Medical Network has entered a strategic partnership with Molecular Testing Labs (MTL) to enhance its in-home diagnostic services through advanced molecular diagnostics and novel sample collection kits. The collaboration aims to improve diagnostic accuracy, expand access to care in remote areas, and utilize AI-driven analytics to better detect chronic illnesses. This initiative supports Matrix's mission to provide high-quality, patient-centered home-based health assessments for Medicare Advantage and Managed Medicaid members.PR NewswireAlliance for Accessible Patient-Centered Testing (AAPT) Launches with Founding Members Molecular Testing Labs, Previon, and IHDLabThe Alliance for Accessible Patient-Centered Testing (AAPT) officially launched on June 12, 2024, with founding members Molecular Testing Labs, Previon, and IHDLab. The alliance aims to improve access to diagnostic care by reducing geographic, financial, and stigma barriers through at-home and remote self-collected testing options.PR NewswireMolecular Testing Labs Announces Selection of Jason Hall as New CFOMolecular Testing Labs has appointed Jason Hall as its new Chief Financial Officer following a national search. Hall brings over 20 years of financial leadership experience from previous roles at healthtech firms such as CareXM and Practice Fusion to support the company's rapid growth phase.BioSpaceMolecular Testing Labs Announces Selection of Eric Strafel as New CEOMolecular Testing Labs selected Eric Strafel as CEO after a national search. Strafel previously led Aviall, where he grew annual revenues to over $5 billion. He will bring his experience in scaling innovative technologies to the company.PR NewswireMolecular Testing Labs Partners With Concentric By Ginkgo To Provide Pooled COVID-19 Testing For K-12 Schools Across The CountryMolecular Testing Labs has partnered with Concentric by Ginkgo, the biosecurity effort at Ginkgo Bioworks, to offer pooled COVID-19 testing for K-12 schools across the United States. Ginkgo, which currently provides testing at over 800 schools across more than a dozen states, will supply the test kits while Molecular will analyze the samples, with results delivered within 48 hours at costs as low as $6 per person. The partnership is designed to expand the reach of the $12 billion in COVID-19 testing investment by the Biden Administration and enable frequent, affordable testing for students and teachers.